Revvity, Inc.

RVTYNYSEUSD
93.97 USD
2.41 (2.50%)AT CLOSE (11:59 AM EDT)
94.15
0.18 (0.19%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
94.15
0.18 (0.19%)
🔴Market: CLOSED
Open?$94.45
High?$95.62
Low?$93.83
Prev. Close?$96.38
Volume?1.2M
Avg. Volume?1.3M
VWAP?$94.53
Rel. Volume?0.92x
Bid / Ask
Bid?$91.90 × 100
Ask?$95.00 × 200
Spread?$3.10
Midpoint?$93.45
Valuation & Ratios
Market Cap?10.5B
Shares Out?111.8M
Float?113.0M
Float %?99.7%
P/E Ratio?43.74
P/B Ratio?1.46
EPS?$2.15
Dividend?0.31%
Ex-Dividend?2026-07-17
News
Profile
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Employees
11.0K
Market Cap
10.8B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1972-06-01
Address
77 4TH AVENUE
WALTHAM, MA 02451
Phone: 781-663-6900
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.72Adequate
Quick Ratio?1.41Adequate
Cash Ratio?0.69Adequate
Debt/Equity?0.45Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
43.7PRICEY
P/B?
1.46CHEAP
P/S?
3.61FAIR
P/FCF?
21.3FAIR
EV/EBITDA?
16.6FAIR
EV/Sales?
4.42FAIR
Returns & Efficiency
ROE?
3.3%WEAK
ROA?
2.0%WEAK
Cash Flow & Enterprise
FCF?$492.7M
Enterprise Value?$12.8B
Fundamentals ratios updated end of day